Showing results (551-560 of 589) with videos related to

Sort By:
Pageof 59
JAMA|July 13, 2006
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 MutationAmy Finch, Mario Beiner, Jan Lubinski, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2014
Ketoconazole in Cushing's disease: is it worth a try?Frederic Castinetti, Laurence Guignat, Pauline Giraud, et al.
Breast Cancer Research and Treatment|October 19, 2013
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutationAdriana Valentini, Jan Lubinski, Tomasz Byrski, et al.
JAMA Oncology|February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
The Journal of Allergy and Clinical Immunology|August 2, 2016
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cellsHannah H Chen, Norman Händel, Joanne Ngeow, et al.
The Lancet. Diabetes & Endocrinology|January 21, 2019
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective studyFrederic Castinetti, Steven G Waguespack, Andreas Machens, et al.
JCO Precision Oncology|November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry CompositionElisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2024
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factorsBrent Mabey, Elisha Hughes, Matthew Kucera, et al.
Pageof 59